Natural Biologics recently introduced Optishield, a new and innovative product delivering proven results against lipid-membraned viruses such as porcine epidemic diarrhea virus (PEDV), porcine reproductive and respiratory syndrome virus (PRRSV) and African swine fever (ASF) virus.
Optishield is a unique combination of monoglycerides, surfactants and immune-supporting oligosaccharides, the company said, noting that new research shows that Optishield’s unique monoglycerides are at least 20 times more potent against the ASF virus than free, or activated, medium-chain fatty acids.
In a recent webinar held in conjunction with the Global Hog Industry Virtual Conference, Natural Biologics president Dr. Charlie Elrod said, “In collaboration with leading scientists around the world, Natural Biologics has identified the combination of monoglycerides that offers the greatest efficacy against lipid-membraned viruses.”
Elrod added, “Through detailed biophysical studies of lipids and viral membranes, Natural Biologics has created an optimal formulation to deliver the most efficient and cost-effective protection in the industry. Not only against ASF, but also against PRRSV, PEDV and pathogenic bacteria like salmonella.”
Natural Biologics also presented research at the 2020 Cornell Nutrition Conference and the 2020 Leman Swine Conference, all supporting the efficacy of the monoglycerides in Optishield. Natural Biologics has also developed a new video explaining the mode of action and chemistry behind this one-of-a-kind formulation.
Natural Biologics was founded in 2015 out of a desire to bring innovation and scientific validation to the development of natural solutions for the many animal health challenges of today.